Article Text

PDF

Neonatal screening for cystic fibrosis.
  1. F Bowling,
  2. G Cleghorn,
  3. A Chester,
  4. J Curran,
  5. B Griffin,
  6. J Prado,
  7. P Francis,
  8. R Shepherd
  1. Neonatal Screening Laboratory, State Department of Health, Royal Children's Hospital, Brisbane, Australia.

    Abstract

    Two groups of patients with cystic fibrosis were compared. The screened group, detected with an improved neonatal screening assay for immunoreactive trypsin, developed fewer chest infections requiring treatment and gained more weight than the unscreened group. Early diagnosis by screening seems to affect early morbidity.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.